Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Significant differences in genotoxicity induced by retrovirus integration in human T cells and induced pluripotent stem cells.

Zheng W, Wang Y, Chang T, Huang H, Yee JK.

Gene. 2013 Apr 25;519(1):142-9. doi: 10.1016/j.gene.2013.01.009. Epub 2013 Jan 31.

2.

Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.

Steichen C, Luce E, Maluenda J, Tosca L, Moreno-Gimeno I, Desterke C, Dianat N, Goulinet-Mainot S, Awan-Toor S, Burks D, Marie J, Weber A, Tachdjian G, Melki J, Dubart-Kupperschmitt A.

Stem Cells Transl Med. 2014 Jun;3(6):686-91. doi: 10.5966/sctm.2013-0158. Epub 2014 Apr 15.

3.

Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.

Phang RZ, Tay FC, Goh SL, Lau CH, Zhu H, Tan WK, Liang Q, Chen C, Du S, Li Z, Tay JC, Wu C, Zeng J, Fan W, Toh HC, Wang S.

Stem Cells Transl Med. 2013 Dec;2(12):935-45. doi: 10.5966/sctm.2013-0043. Epub 2013 Oct 28.

4.

Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.

Sommer CA, Christodoulou C, Gianotti-Sommer A, Shen SS, Sailaja BS, Hezroni H, Spira A, Meshorer E, Kotton DN, Mostoslavsky G.

PLoS One. 2012;7(12):e51711. doi: 10.1371/journal.pone.0051711. Epub 2012 Dec 14.

5.

Lack of genotoxicity due to foamy virus vector integration in human iPSCs.

Deyle DR, Khan IF, Ren G, Russell DW.

Gene Ther. 2013 Aug;20(8):868-73. doi: 10.1038/gt.2013.6. Epub 2013 Feb 7.

6.

Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.

Fuchs NV, Loewer S, Daley GQ, Izsvák Z, Löwer J, Löwer R.

Retrovirology. 2013 Oct 24;10:115. doi: 10.1186/1742-4690-10-115.

7.
8.

Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.

Jin ZB, Okamoto S, Xiang P, Takahashi M.

Stem Cells Transl Med. 2012 Jun;1(6):503-9. doi: 10.5966/sctm.2012-0005. Epub 2012 Jun 1.

9.

Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.

Tubsuwan A, Abed S, Deichmann A, Kardel MD, Bartholomä C, Cheung A, Negre O, Kadri Z, Fucharoen S, von Kalle C, Payen E, Chrétien S, Schmidt M, Eaves CJ, Leboulch P, Maouche-Chrétien L.

Stem Cells. 2013 Sep;31(9):1785-94. doi: 10.1002/stem.1436.

10.

Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.

Leng L, Tan Y, Gong F, Hu L, Ouyang Q, Zhao Y, Lu G, Lin G.

Hum Reprod. 2015 Mar;30(3):737-48. doi: 10.1093/humrep/deu358. Epub 2015 Jan 12.

PMID:
25586786
11.

A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny.

Pfaff N, Lachmann N, Ackermann M, Kohlscheen S, Brendel C, Maetzig T, Niemann H, Antoniou MN, Grez M, Schambach A, Cantz T, Moritz T.

Stem Cells. 2013 Mar;31(3):488-99. doi: 10.1002/stem.1316.

12.
13.

Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?

Boué S, Paramonov I, Barrero MJ, Izpisúa Belmonte JC.

PLoS One. 2010 Sep 17;5(9). pii: e12664. doi: 10.1371/journal.pone.0012664.

14.

Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.

Mou X, Wu Y, Cao H, Meng Q, Wang Q, Sun C, Hu S, Ma Y, Zhang H.

Stem Cell Res Ther. 2012 Apr 18;3(2):14. doi: 10.1186/scrt105.

15.

Reprogramming human somatic cells into induced pluripotent stem cells (iPSCs) using retroviral vector with GFP.

Kim KY, Hysolli E, Park IH.

J Vis Exp. 2012 Apr 3;(62). pii: 3804. doi: 10.3791/3804.

16.

Evolution of induced pluripotent stem cell technology.

Zhou H, Ding S.

Curr Opin Hematol. 2010 Jul;17(4):276-80. doi: 10.1097/MOH.0b013e328339f2ee. Review.

PMID:
20442654
17.

Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.

Ohnuki M, Tanabe K, Sutou K, Teramoto I, Sawamura Y, Narita M, Nakamura M, Tokunaga Y, Nakamura M, Watanabe A, Yamanaka S, Takahashi K.

Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12426-31. doi: 10.1073/pnas.1413299111. Epub 2014 Aug 5.

18.

Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer.

Miller JD, Schlaeger TM.

Methods Mol Biol. 2011;767:55-65. doi: 10.1007/978-1-61779-201-4_5.

PMID:
21822867
19.

Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells.

Lorenzo IM, Fleischer A, Bachiller D.

Stem Cell Rev. 2013 Aug;9(4):435-50. doi: 10.1007/s12015-012-9412-5.

PMID:
23104133
20.

Possible linkages between the inner and outer cellular states of human induced pluripotent stem cells.

Saito S, Onuma Y, Ito Y, Tateno H, Toyoda M, Hidenori A, Nishino K, Chikazawa E, Fukawatase Y, Miyagawa Y, Okita H, Kiyokawa N, Shimma Y, Umezawa A, Hirabayashi J, Horimoto K, Asashima M.

BMC Syst Biol. 2011 Jun 20;5 Suppl 1:S17. doi: 10.1186/1752-0509-5-S1-S17.

Supplemental Content

Support Center